Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'bax inhibitor peptide negative control'

Search results for: 'bax inhibitor peptide negative control'

Items 1-10 of 113

Page
per page
  1. IRAK-1-4 Inhibitor I
    A3505 IRAK-1-4 Inhibitor I
     3 Citation
    Target: IRAK
    Summary: IRAK-1/4 inhibitor
      insoluble in H2O; insoluble in EtOH; ≥19.75 mg/mL
  2. IRAK inhibitor 1
    A3500 IRAK inhibitor 1
     2 Citation
    Target: IRAK
    Summary: IRAK-4 inhibitor
      insoluble in EtOH; insoluble in H2O; ≥14.4 mg/mL
  3. IRAK inhibitor 6
    A3504 IRAK inhibitor 6
    Target: IRAK
    Summary: IRAK-4 inhibitor
      insoluble in EtOH; insoluble in H2O; ≥9.9 mg/mL
  4. Tie2 kinase inhibitor
    A5979 Tie2 kinase inhibitor
    Target: Tie-2
    Summary: Tie-2(Tie2 ) inhibitor
      ≥22 mg/mL
  5. ALW-II-41-27
    A3165 ALW-II-41-27
     1 Citation
    Target: Eph Receptors
    Summary: Eph receptor inhibitor
      ≥60.8 mg/mL
  6. AG-490
    A4139 AG-490
     3 Citation
    Target: EGFR|JAK
    Summary: JAK2/EGFR inhibitor
      insoluble in H2O; ≥14.7 mg/mL
  7. BLU9931
    A8706 BLU9931
    Target: FGFR
    Summary: FGFR4 inhibitor,potent and irreversible
      ≥50.9 mg/mL
  8. AZD-3463
    A8620 AZD-3463
     3 Citation
    Target: ALK|Insulin-like growth factors (IGFs)
    Summary: ALK/IGF1R inhibitor
      insoluble in H2O; insoluble in EtOH; ≥11.22 mg/mL
  9. Ponatinib (AP24534)
    A5467 Ponatinib (AP24534)
     1 Citation
    Target: VEGFR|PDGFR|Bcr-Abl|FGFR|Src
    Summary: pan-BCR-ABL inhibitor,multi-kinase inhibitor
      ≥53.3 mg/mL
  10. Crenolanib (CP-868596)
    A8307 Crenolanib (CP-868596)
     1 Citation
    Target: FLT3|PDGFR
    Summary: PDGFR-β inhibitor,potent and selective
      ≥22.2 mg/mL

Items 1-10 of 113

Page
per page
Shop By
Now Shopping by
  1. Category Tyrosine Kinase Remove This Item
  2. Specificity Selective Remove This Item
Clear All
Shopping Options
Category
  1. Bcr-Abl 5item
  2. Axl 4item
  3. ALK 9item
  4. Broad Spectrum Protein Kinase Inhibitor 1 item
  5. c-FMS 1 item
  6. c-Kit 3item
  7. c-MET 13item
  8. c-RET 2item
  9. CSF-1R 3item
  10. EGFR 14item
  11. EphB4 1 item
  12. FAK 4item
  13. FGFR 8item
  14. FLT3 6item
  15. HER2 5item
  16. IGF1R 4item
  17. IRAK 3item
  18. ITK 1 item
  19. LRRK2 4item
  20. PDGFR 12item
  21. Pyk2 2item
  22. Spleen Tyrosine Kinase (Syk) 6item
  23. Src 5item
  24. Tie-2 2item
  25. Trk 3item
  26. VEGFR 18item
Reversibility
  1. Reversible 7item
  2. Irreversible 4item
Target
  1. Cyclin-Dependent Kinases 1 item
  2. Raf 3item
  3. Aurora Kinases 1 item
  4. CSF-1R 2item
  5. MER 1 item
  6. FLT3 9item
  7. Eph Receptors 2item
  8. VEGFR 24item
  9. PDGFR 16item
  10. c-Kit 7item
  11. RET 3item
  12. IRAK 3item
  13. Bcr-Abl 8item
  14. FGFR 9item
  15. Insulin-like growth factor receptors(IGFRs) 1 item
  16. MET 7item
  17. Src 7item
  18. Trk Receptors 4item
  19. EGFR 14item
  20. FAK 4item
  21. BMP and Other Activin Receptors 3item
  22. JAK 2item
  23. Syk 6item
  24. ErbB 2item
  25. c-MET 8item
  26. PKC 1 item
  27. Ca2 /calmodulin-dependent protein kinases (CaMKs) 1 item
  28. Lyn 1 item
  29. HER2 2item
  30. Pyk2 3item
  31. LRRK2 4item
  32. Insulin and Insulin-like Receptors 2item
  33. ALK 4item
  34. ROS1 2item
  35. PKG 1 item
  36. PKA 1 item
  37. Myosin light chain kinases (MLCKs) 1 item
  38. Insulin-like growth factors (IGFs) 1 item
  39. CSF1R 1 item
  40. Tie-2 3item
  41. RSK 1 item
  42. p70 S6K 1 item
  43. Ron 1 item
  44. c-Fyn 1 item
  45. Insulin Receptors 1 item
  46. IRG-1R 1 item
  47. ZAP-70 1 item
  48. Flk-1 1 item
  49. TAM kinase 1 item
  50. AXL 1 item
  51. c-Fms tyrosine kinase 1 item
  52. ITK 1 item
  53. DCLK2 1 item
  54. tropomyosin receptor kinase 1 item
  55. Insulin Receptor 1 item
Reported Experiments
  1. Animal Experiments 101item
  2. Cell Experiments 59item
Related Disease
  1. Acute Myelogenous Leukemia 1 item
  2. Acute Myeloid Leukemia 5item
  3. Adrenocortical Carcinoma 1 item
  4. Advanced Renal Cell Carcinoma 1 item
  5. Autoimmune Diseases 1 item
  6. Bladder Cancer 4item
  7. Bladder Carcinoma 1 item
  8. Breast Cancer 19item
  9. Cancer 82item
  10. Cervical Cancer 1 item
  11. Cholangiocarcinoma 1 item
  12. Chronic Lymphocytic Leukemia 1 item
  13. Clear Cell Renal Cell Carcinoma 1 item
  14. Colon Cancer 3item
  15. Colon Carcinoma 3item
  16. Colorectal Cancer 12item
  17. Glioblastoma 9item
  18. Glioma 4item
  19. Hepatocellular Carcinoma 3item
  20. Leukemia 2item
  21. Liver Cancer 2item
  22. Lung Cancer 8item
  23. Lung Carcinoma 4item
  24. Lymphoma 5item
  25. Melanoma 3item
  26. Multiple Myeloma 5item
  27. Myeloma 1 item
  28. Neuroblastoma 2item
  29. Non-small Cell Lung Cancer 6item
  30. Ovarian Cancer 7item
  31. Pancreatic Cancer 12item
  32. Prostate Cancer 7item
  33. Pulmonary Arterial Hypertension 1 item
  34. Renal Cancer 2item
  35. Renal Cell Carcinoma 4item
  36. Rheumatoid Arthritis 2item
  37. Thyroid Cancer 4item